Search results
Results From The WOW.Com Content Network
In 2010, the research and development cost of each new molecular entity was about US$1.8 billion. [7] In the 21st century, basic discovery research is funded primarily by governments and by philanthropic organizations, while late-stage development is funded primarily by pharmaceutical companies or venture capitalists. [8]
2. Pre-existing theories of disease: Before a pathogen is well-recognized, scientists may attribute the symptoms of infection to other causes, such as toxicological, psychological, or genetic causes. Once a pathogen has been associated with an illness, researchers have reported difficulty displacing these pre-existing theories. [3] [4] 3.
Gain-of-function research (GoF research or GoFR) is medical research that genetically alters an organism in a way that may enhance the biological functions of gene products. This may include an altered pathogenesis , transmissibility , or host range , i.e., the types of hosts that a microorganism can infect.
Rare diseases affect between 20 and 30 million Americans each year, and around 350 million people all over the world. Any disease that impacts 200,000 people or less in the U.S. is classified as a ...
July 31: The New York Times publishes an article by its medical correspondent Dr. Lawrence K. Altman on the possible link between H. pylori and PUD. [42] He states in 2002, "I’ve never seen the medical community more defensive or more critical of a story" since he joined the newspaper in 1969. [43]
According to a new study, flexibility is linked with living longer. Personal trainers and dietitians explain why—and how you can become more flexible. Researchers Gave 3,100 People A Flexibility ...
Scientists report that a new genetic test could diagnose the risk of breast cancer years before the disease actually develops, allowing much more effective early treatment. [72] [73] French researchers successfully create silicene, a one-atom-thick sheet of silicon that is analogous to the much-vaunted graphene.
The French doctor Charles Anglada (1809–1878) wrote a book in 1869 on extinct and new diseases. [16] He did not distinguish infectious diseases from others (he uses the terms reactive and affective diseases, to mean diseases with an external or internal cause, more or less meaning diseases with or without an observable external cause).